Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Type 2 Diabetes Mellitus Article
This is a selection made from among articles on Drug Treatment Type 2 Diabetes Mellitus. For a permanent link to this article, or to bookmark it for future reading, click here.
from:
Why You Need Drug Or Alcohol Rehab Centers
By Ras Reed
Drug or Alcoholic addiction is a serious problem among millions of Americans in particular and the world over. Whether you inherited it or just chose to go into it, alcohol addiction does more than good to many of its victims. Though the victim seems to be enjoying himself or herself oblivious of the many dangers he or she is exposed to. Much material and physical has been the lot of many alcohol addicts. Where can you get help? An alcohol rehab center is your sure bet. This is the last beacon of hope for you.
But the good news is that there are many alcohol rehab centers all over the world and the US in particular. These centers major aim is to assist addicts and their concerned families in getting off the bondage of addiction and begin to live a new life.
Many of the alcohol centers out there are unique in the type of services they offer. Some centers use the medical approach to help the addicts. Before coming into the center, the addict’s body is already conditioned into using the drugs and therefore needs to change its way of working after getting off addiction. This is more fatal when you do it on your own. Your body reacts violently if you don’t give it what it needs. But the medical doctor or professional will help your body adjust by giving you appropriate drugs that will bring your body back to its natural state.
Some other centers use the psychological approach using therapy and counselors to assist the addicts get off alcohol addiction. The counseling session might be done in private or group basis. The session also includes questions and answers time that will afford you to ask any question you want.
When a victim of addiction is told about entering into an alcohol or drug rehab centers, the news is not often received happily. This is borne out of the sense of shame and worthlessness that an addict often feels and therefore reject going into a rehab center.
But it needs to be stressed that you need to check into a rehab center fast. You can’t probably do it on your own. You need the help of professionals that you can only get from good and reliable centers. The center will not only help you get off addiction, it will also help you begin a new lease of productive life.
You won’t have problem finding a rehab center near you. Visit online directories where the list of reputable rehab centers are provided and type in your location. You’ll get the list of good centers. Contact them personally and see how they can help you achieve your goal. Good luck.
Ras Reed provides more detailed and free information on his website. Check it out at Drug Rehab Centers Zone.
Article Source: http://EzineArticles.com/?expert=Ras_Reed
http://EzineArticles.com/?Why-You-Need-Drug-Or-Alcohol-Rehab-Centers&id=344339
Drug Treatment Type 2 Diabetes Mellitus Specific links
Drug Treatment Type 2 Diabetes Mellitus News
FDA Approves Levemir® for Expanded Use in Children Two to Five Years of Age with Type 1 Diabetes
PRINCETON, N.J., May 22, 2012 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, announced today that the U.S. Food and Drug Administration (FDA) has approved Levemir ® (insulin detemir [rDNA ...
Read more...Linagliptin safe and effective for African American patients with type 2 diabetes
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced Phase 3 study results for linagliptin 5 mg once-daily, which showed significant hemoglobin A1c (HbA1c or A1C) reduction of 0.88 percent compared to 0.24 percent in the placebo group (p=0.0002) at 24 weeks in black or African American adult patients with type 2 diabetes whose blood sugar was not adequately ...
Read more...New Phase 3 data for Tradjenta® (linagliptin) tablets in black or African American patients with type 2 diabetes ...
RIDGEFIELD, Conn. and INDIANAPOLIS, May 24, 2012 /PRNewswire/ --Â Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) today announced Phase 3 study results for linagliptin 5 ...
Read more...Apofore Founder Publishes Studies Identifying Apolipoprotein A-IV as New Potential Target for Type 2 Diabetes ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apolipoprotein A-IV identified as potential Type 2 diabetes drug target in studies published by Apofore Corporation scientific founder
Read more...Baxter’s Low Glucose PD Solutions Favorably Impacted Metabolic Measures Including Glycemic Control in Trials of ...
Baxter International Inc. today announced results from two large, international multicenter trials demonstrating that a low glucose peritoneal dialysis regimen favorably impacted metabolic measures important for end-stage renal disease patients with diabetes, including blood glucose control and selected lipids .
Read more...ASH Annual Scientific Meeting Features Several Late-Breaking Presentations
NEW YORK, May 22, 2012 /PRNewswire/ --Â The 27th Annual Scientific Meeting of the American Society of Hypertension (ASH) will feature presentations of several late-breaking clinical trials, which will highlight ...
Read more...Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe
As EuroPCR 2012 gets under way today, Medtronic, Inc. announced that the Resolute Integrity Coronary Stent System has received European regulatory approval for several
Read more...Takeda Announces the Acceptance of the European Medicines Agency Submission of Alogliptin for the Treatment of Type 2 ...
LONDON and OSAKA, Japan, May 23, 2012 /PRNewswire/ Takeda Pharmaceutical Company Ltd. (Takeda) today announced that Takeda Global Research & Development Centre (Europe) Ltd. ("TGRD Europe") received confirmation of the acceptance of the …
Read more...Corcept Therapeutics Announces First Quarter Results and Corporate and Development Update
MENLO PARK, CA-- - Corcept Therapeutics Incorporated , a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic and psychiatric ...
Read more...Press Release
Medtronic Inc. Posted on:16 May 12 As EuroPCR 2012 gets under way today, Medtronic, Inc. (NYSE: MDT) announced that the Resolute Integrity Coronary Stent System has received European regulatory approval for several new indications, making it the drug-eluting stent (DES) with the broadest range of approved indications in Europe.
Read more...